Search Results - raphael+rozenfeld

1 Results Sort By:
Antibodies Targeting CB1/AT1R or CB1/A2aR Heteromers to Treat Liver Fibrosis
Thank you for your interest in this technology. Please see our technology brief here: https://app.in-part.com/articles/9y5gxRj67BLK
Published: 10/23/2024   |   Inventor(s): Lakshmi Arehole Devi, Raphael Rozenfeld
Keywords(s): Fibrosis, Liver Disease
Category(s): Therapeutic